Roche Holding Ltd. (VTX:ROG)‘s stock had its “buy” rating reissued by equities researchers at JPMorgan Chase & Co. in a report issued on Wednesday.

Separately, Citigroup Inc. reissued a “buy” rating on shares of Roche Holding in a report on Thursday, November 3rd.

Roche Holding (VTX:ROG) opened at 223.80 on Wednesday. The firm’s 50-day moving average price is CHK 231.09 and its 200-day moving average price is CHK 243.16. The company has a market capitalization of CHK 190.71 billion and a price-to-earnings ratio of 21.26. Roche Holding has a 52 week low of CHK 219.20 and a 52 week high of CHK 281.40.

TRADEMARK VIOLATION WARNING: This report was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another website, it was illegally copied and republished in violation of international trademark & copyright laws. The correct version of this report can be read at

About Roche Holding

Roche Holding AG is a research-based healthcare company. The Company develops, manufactures and delivers medicines, and diagnostic instruments and tests. Its operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. Its Pharmaceuticals division consists of two business segments: Roche Pharmaceuticals and Chugai.

Receive News & Stock Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related stocks with our FREE daily email newsletter.